bioRxiv Science⌕ Search

bioRxiv · 10.1101/2025.08.02.668261

TICToK: A comprehensive knowledgebase of tattoo ink chemicals and investigation of their associated toxicities and regulations

Abstract

Tattoos and permanent make-up, involving dermal injection of chemicals, are increasingly popular, with 30-40% of young adults in North America and Europe having at least one tattoo. Recent studies have suggested a possible association between tattooing and health risks, including skin cancers and lymphomas, although no definitive link has yet been established. This study comprehensively catalogs tattoo ink chemicals and investigates their potential adverse effects, addressing the urgent need for greater understanding of tattoo-related health concerns. First, 364 unique tattoo chemicals were identified from various scientific and regulatory sources, with nearly half functioning as pigments. Hazardous chemicals were identified, revealing carcinogens, endocrine disruptors, neurotoxicants, and dermal toxicants. A regulatory analysis based on key EU regulations, including harmonised classifications under Classification, Labelling and Packaging (CLP) regulation, Restriction Entry 75 of the REACH regulation, Cosmetic Products Regulation (CPR), and SVHC candidate list, revealed existing regulatory coverage of tattoo ink chemicals. Curated chemical-disease associations highlighted that some tattoo chemicals are known to cause dermatitis. Further, diverse toxicological information, including experimental results from REACH dossiers, were integrated to construct stressor-AOP network linking 151 chemicals to 362 AOPs, revealing potential carcinogenic mechanisms associated with tattoo ink chemicals. A systems biology approach revealed potential immunomodulatory effects associated with these chemicals. Finally, all findings have been made available through the online database Tattoo Ink Chemicals and associated Toxicities Knowledgebase (TICToK; https://cb.imsc.res.in/tictok), which can support risk assessment and sustainable tattoo practices. Graphical Abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=81 SRC="FIGDIR/small/668261v2_ufig1.gif" ALT="Figure 1"> View larger version (37K): org.highwire.dtl.DTLVardef@6ce8e3org.highwire.dtl.DTLVardef@2dc5aborg.highwire.dtl.DTLVardef@10c67e6org.highwire.dtl.DTLVardef@1795281_HPS_FORMAT_FIGEXP M_FIG C_FIG

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Chivukula, N., Madgaonkar, S. R., Marigoudar, S. R., Sharma, K. V., Kishore, V., Singh, A. V., Samal, A.. 2025-08-02. TICToK: A comprehensive knowledgebase of tattoo ink chemicals and investigation of their associated toxicities and regulations. https://doi.org/10.1101/2025.08.02.668261

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Translational Pharmacokinetics and Pharmacodynamics of a Cationic mRNA-Lipid Nanoparticle from Mice to Non-Human Primates

Cationic lipid nanoparticles have demonstrated unique potential for extrahepatic mRNA delivery, particularly enabling selective targeting of the pulmonary endothelium. However, their translational development has been hampered by reports of infusion-related immune reactions and innate immune system activation, most notably transient complement activation. Here, we present a case study illustrating the discovery and translational advancement of a selected cationic LNP into non-human primates (NHPs) for initial pharmacokinetic assessment and evaluation of potential immunostimulatory side effects. We show surface charge dependent organ-selective expression of reporter mRNAs from different LNPs in vivo. An mRNA encoding the Tie2 agonist COMP-Angl, was formulated with LNP002, and respective pharmacokinetic and pharmacodynamic readouts were analyzed in two independent non-human primate studies. Notably, dose-dependent transient complement activation could be abrogated by extending the infusion time. Finally, we identified the blood-borne pharmacodynamic biomarker PDGFB for LNP002/mRNA-76 treatment reflecting activated Tie2-signalling in healthy pulmonary endothelium in vivo supported by single cell sequencing and cluster-alignment of downstream effector genes with the same spatial profile as the delivered mRNA.

pharmacology and toxicology↗

Cytotoxic Effects of Multiple Pesticides and their Mixtures on Caco-2 Cells Evaluated by Using MTT and Trypan Blue Assays

BACKGROUND: Pesticides are extensively used in agriculture, raising concerns about their potential impact on human health through dietary and environmental exposure. OBJECTIVES: This study evaluated the in vitro cytotoxicity of ten commonly used pesticides and their mixtures (lambda-cyhalothrin, cypermethrin, deltamethrin, tebuconazole, glyphosate, acetamiprid, cyprodinil, piperonyl butoxide, fluopyram, and imazalil) on human intestinal Caco-2 cells. METHODS: Cytotoxicity was assessed using the MTT assay, as a measure of metabolic activity, and the trypan blue exclusion test, as an indicator of cell membrane integrity. FINDINGS: Results showed that high concentrations (100 mg/L) of all pesticides significantly reduced cell viability and vitality. Notably, glyphosate and tebuconazole exhibited significant toxicity even at lower concentrations, respectively 0.1 mg/L and 10 mg/L. Combination treatments (Top 3 and Top 8 pesticide mixtures) retained the cytotoxic effects observed for individual compounds, showing additive (non-synergistic) effects. CONCLUSIONS: Overall, these findings indicate that certain pesticides-based herbicides can exert cytotoxic effects on intestinal cells even at relatively low concentrations and highlight the importance of using the component-based approach in mixture risk assessment for humans. This study was performed as part of the EU SPRINT (Sustainable Plant Protection Transition: A Global Health Approach) project.

pharmacology and toxicology↗

Assessing chemical toxicity across Eukaryota using multimodal transformers

Biodiversity is globally threatened by chemical pollution, yet toxicity data remain unavailable for millions of species and tens of thousands of chemicals, severely limiting our ability to assess ecological impacts. Here we present TRIDENT-2, a multimodal artificial intelligence model for predicting chemical toxicity across evolutionarily diverse eukaryotic species. Trained on 560,780 toxicity assays spanning 82,775 chemicals, 6,793 species, and multiple exposure scenarios, TRIDENT-2 accurately predicts toxicity across Eukaryota with an average median absolute error ranging from 1.76 to 3.80. By jointly learning from chemical, biological, and experimental information, it remains accurate across broad chemical and taxonomic distances, allowing for toxicity assessment for species and chemicals beyond the current experimental evidence. Our findings demonstrate that artificial intelligence can help overcome longstanding data limitations in ecotoxicology, paving the way for improved decision-making and reducing chemical impacts on biodiversity and ecosystems.

pharmacology and toxicology↗